Cognitive and Speech Disorders in Children With Congenital Heart Defects
NCT ID: NCT06565299
Last Updated: 2024-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
217 participants
OBSERVATIONAL
2019-03-01
2024-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High and Low Intensity Speech Intervention in Children With a Cleft Palate: Perceptions of Children, Their Caregivers and Speech-language Pathologists
NCT06895395
Language Intervention Training for Cognitive Protection in High-risk Cardio-Cerebrovascular Elderly Population
NCT06898931
Effect of Performance-specific Cleft Speech Intervention and Long-term Learning in Children With a Cleft Palate
NCT06105099
Cognitive Impairments in Children With Epilepsy
NCT05097742
Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)
NCT05312177
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Children with family anamnesis confounding factorss, such as family composition, living conditions, conflict families (members of family suffering from any type of addiction, prisoned members of family, conflicts in front of a child's eyes).
Cardiovascular surgery with cardiopulmonary bypass
Cardiovascular surgery about congenital heart defects with cardiopulmonary bypass
Group 2
without family anamnesis confounding factors
Cardiovascular surgery with cardiopulmonary bypass
Cardiovascular surgery about congenital heart defects with cardiopulmonary bypass
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiovascular surgery with cardiopulmonary bypass
Cardiovascular surgery about congenital heart defects with cardiopulmonary bypass
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
5 Years
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kemerovo State Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Evgeny Grigoryev
Head of the Department of Anesthesiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aleksandra Aeksandrovna Rumiantseva
Kemerovo, Kemerovo Oblast, Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.